Cargando…

Targeted Delivery of VP1 Antigen of Foot-and-mouth Disease Virus to M Cells Enhances the Antigen-specific Systemic and Mucosal Immune Response

Application of vaccine materials through oral mucosal route confers great economical advantage in animal farming industry due to much less vaccination cost compared with that of injection-based vaccination. In particular, oral administration of recombinant protein antigen against foot-and-mouth dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sae-Hae, Lee, Ha-Yan, Jang, Yong-Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759713/ https://www.ncbi.nlm.nih.gov/pubmed/24009543 http://dx.doi.org/10.4110/in.2013.13.4.157

Ejemplares similares

Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines
por: Kim, Sae-Hae, et al.
Publicado: (2014)

Protective Immunity Elicited by VP1 Chimeric Antigens of Bacterial Ghosts against Hand-Foot-and-Mouth Disease Virus
por: Gong, Saisai, et al.
Publicado: (2020)

Antigenic heterogeneity of capsid protein VP1 in foot-and-mouth disease virus (FMDV) serotype Asia 1
por: Alam, SM Sabbir, et al.
Publicado: (2013)

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
por: Park, Sun Young, et al.
Publicado: (2022)

Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles
por: Pan, Li, et al.
Publicado: (2014)

Tracking the Antigenic Evolution of Foot-and-Mouth Disease Virus
por: Reeve, Richard, et al.
Publicado: (2016)

Targeted Delivery of GP5 Antigen of PRRSV to M Cells Enhances the Antigen-Specific Systemic and Mucosal Immune Responses
por: Du, Luping, et al.
Publicado: (2018)

Effects of amino acid substitutions in the VP2 B-C loop on antigenicity and pathogenicity of serotype Asia1 foot-and-mouth disease virus
por: Xue, Mei, et al.
Publicado: (2012)

Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination
por: Kim, Sae-Hae, et al.
Publicado: (2012)

Production of foot-and-mouth disease virus SAT2 VP1 protein
por: Mamabolo, Mpho Victoria, et al.
Publicado: (2020)

Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes
por: Park, Jong Hyeon, et al.
Publicado: (2006)

Bacterial Toxin Fusion Proteins Elicit Mucosal Immunity against a Foot-and-Mouth Disease Virus Antigen When Administered Intranasally to Guinea Pigs
por: Challa, Sreerupa, et al.
Publicado: (2011)

Immune Modulatory Potential of Anti-idiotype Antibodies as a Surrogate of Foot-and-Mouth Disease Virus Antigen
por: Naveed, Ahsan, et al.
Publicado: (2018)

Expression of the ATP-gated P2X(7) Receptor on M Cells and Its Modulating Role in the Mucosal Immune Environment
por: Kim, Sae-Hae, et al.
Publicado: (2015)

The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants
por: Kim, Sae-Hae, et al.
Publicado: (2017)

Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against infection
por: Yang, Ye Lin, et al.
Publicado: (2022)

Development and Evaluation of a Rapid Antigen Detection and Serotyping Lateral Flow Antigen Detection System for Foot-and-Mouth Disease Virus
por: Morioka, Kazuki, et al.
Publicado: (2015)

Intravaginal immunization using a novel antigen delivery device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses
por: McKay, PF, et al.
Publicado: (2012)

Modelling the Influence of Foot-and-Mouth Disease Vaccine Antigen Stability and Dose on the Bovine Immune Response
por: Schley, David, et al.
Publicado: (2012)

Genome Sequences of Antigenically Distinct Serotype O Foot-and-Mouth Disease Viruses from Pakistan
por: Bachanek-Bankowska, Katarzyna, et al.
Publicado: (2019)

Genetic Basis of Antigenic Variation of SAT3 Foot-And-Mouth Disease Viruses in Southern Africa
por: Maake, Lorens, et al.
Publicado: (2020)

PRAGMATIST: A tool to prioritize foot-and-mouth disease virus antigens held in vaccine banks
por: Ludi, Anna B., et al.
Publicado: (2022)

Recent Insights into Cellular Crosstalk in Respiratory and Gastrointestinal Mucosal Immune Systems
por: Kim, Sae-Hae, et al.
Publicado: (2020)

Evolutionary Analysis of Structural Protein Gene VP1 of Foot-and-Mouth Disease Virus Serotype Asia 1
por: Zhang, Qingxun, et al.
Publicado: (2015)

Inhibition of MAVS Aggregation-Mediated Type-I Interferon Signaling by Foot-and-Mouth Disease Virus VP3
por: Ekanayaka, Pathum, et al.
Publicado: (2021)

Foot-and-mouth disease virus VP1 promotes viral replication by regulating the expression of chemokines and GBP1
por: Yang, Li, et al.
Publicado: (2022)

Microarray-based identification of antigenic variants of foot-and-mouth disease virus: a bioinformatics quality assessment
por: Martín, Verónica, et al.
Publicado: (2006)

Sequence-Based Prediction for Vaccine Strain Selection and Identification of Antigenic Variability in Foot-and-Mouth Disease Virus
por: Reeve, Richard, et al.
Publicado: (2010)

Genetic basis of antigenic variation in foot-and-mouth disease serotype A viruses from the Middle East()
por: Upadhyaya, Sasmita, et al.
Publicado: (2014)

Erratum: PRAGMATIST: A tool to prioritize foot-and-mouth disease virus antigens held in vaccine banks
por: Frontiers Production Office,
Publicado: (2023)

Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation
por: Ekanayaka, Pathum, et al.
Publicado: (2020)

Validation of Pretreatment Methods for the In-Process Quantification of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2021)

Novel LysM motifs for antigen display on lactobacilli for mucosal immunization
por: Raya-Tonetti, Fernanda, et al.
Publicado: (2021)

Exploiting the activity of VP22 to enhance the delivery of antigens encoded by DNA vaccine plasmids
por: Roopchand, Vidia, et al.
Publicado: (2006)

Association of Porcine Swine Leukocyte Antigen (SLA) Haplotypes with B- and T-Cell Immune Response to Foot-and-Mouth Disease Virus (FMDV) Peptides
por: de León, Patricia, et al.
Publicado: (2020)

Identification of H-2d Restricted T Cell Epitope of Foot-and-mouth Disease Virus Structural Protein VP1
por: Liu, Xin-Sheng, et al.
Publicado: (2011)

The Kinase STK3 Interacts with the Viral Structural Protein VP1 and Inhibits Foot-and-Mouth Disease Virus Replication
por: Liu, Huisheng, et al.
Publicado: (2017)

Poly (rC) binding protein 2 interacts with VP0 and increases the replication of the foot-and-mouth disease virus
por: Li, Dan, et al.
Publicado: (2019)

Transient inhibition of foot-and-mouth disease virus replication by siRNAs silencing VP1 protein coding region
por: Lv, Ke, et al.
Publicado: (2009)

Engineering Responses to Amino Acid Substitutions in the VP0- and VP3-Coding Regions of PanAsia-1 Strains of Foot-and-Mouth Disease Virus Serotype O
por: Bai, Xing-Wen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1sfq7aa56dsg03mv8d3qbmnka5